Agfa Heartlab Cardiovascular ranks #1 in KLAS report

AGFAAgfa HealthCare announces that its Heartlab cardiovascular solution for cardiology image and information management, received the top rating for Cardiology PACS (Picture Archiving and Communication Systems) in the KLAS Mid-Year Report (June 2006, www.healthcomputing.com). Evaluated against a total of eight Cardiology PACS vendors, Agfa Heartlab Cardiovascular received the highest overall score on KLAS’ detailed analysis of data covering contracting and sales, to implementation, service and upgrade.

KLAS specializes in monitoring and reporting the performance of healthcare information technology vendors. The KLAS database, a repository that serves as the basis of the Mid-Year report, is comprised of feedback from more than 6,000 healthcare executives and facilities. The report ranks 300 vendors and 40 HIT product lines. Agfa's overall score in cardiology has increased by four percent since the last report.

"Agfa HealthCare is continuing the Heartlab legacy of innovation, quality and service," said Mike LaChance, Vice President of Agfa's Cardiovascular Business Unit. "The increase from the last report in our satisfaction rating is testament to our commitment to the service of our customers," he said.

"A vital element of the KLAS data is that it comes from one source, the clients themselves. KLAS is pleased to recognize Agfa Heartlab with the first place Cardiology PACS ranking in the KLAS Mid-Year Top 20 Report," said Ralph Reyes Jr., KLAS Senior VP.

About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging and information technology companies. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), the healthcare sector (Agfa HealthCare) and film related products and specific industrial applications (Agfa Materials). Agfa's headquarters are in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries throughout the world. The Agfa-Gevaert Group achieved a turnover of 3,308 million Euro in 2005.

Agfa HealthCare supplies hospitals and other healthcare centers with state-of-theart systems for the capturing, processing and managing of diagnostic images and with IT solutions that integrate information and imaging workflows into the overall hospital operations across departmental disciplines. In addition, Agfa is a leader in the fast growing market of IT systems that span the entire healthcare enterprise and through which healthcare facilities become more efficient and effective, with improved patient outcomes. For more information on Agfa, visit www.agfa.com.

About KLAS
KLAS began to measure and report Healthcare Information Technology (HIT) vendor performance in 1996. KLAS confidentially interviews thousands of professionals in healthcare annually. The result of the interviews is an extensive performance database representing over 6,000 healthcare facilities and 175 healthcare IT products. Providers, vendors, consultants and investment bankers use KLAS performance reports. For more information contact KLAS Enterprises, LLC at 800-920-4109 or visit the KLAS website at http://www.healthcomputing.com.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...